Thailand Hub of Talents in Cancer Immunotherapy (TTCI Thailand) https://validator.w3.org/feed/docs/rss2.html Member Contents Thailand Hub of Talents in Cancer Immunotherapy (TTCI Thailand) Effective CAR T-cell targeting of an MUC1 cleavage product Our Team CAR T-cell Immunometabolism: Insights from Patients TTCI Showcases Emerging Immuno-Oncology Talent and Invites Global Community to Thailand for WIC-APAC 2027 A Phase 1b clinical trial to evaluate the safety and efficacy of BCMA-targeted CAR T-cell therapy in Thai patients with relapsed or refractory multiple myeloma. A Phase 1b clinical trial to evaluate the safety and efficacy of BCMA-targeted CAR T-cell therapy in Thai patients with relapsed or refractory multiple myeloma. Universal allogeneic CAR T cells engineered with Sleeping Beauty transposons and CRISPR-CAS9 for cancer immunotherapy Division of Hematology, Department of Medicine, Faculty of Medicine Thammasat University Stem Cell and Molecular Biology, Center of Excellence in Stem Cell Research and Innovations, Faculty of Medicine, Thammasat University Department of Paediatrics, Faculty of Medicine, Thammasat University Division of Cell Biology, Department of Preclinical Sciences, Faculty of Medicine, Thammasat University CD70 CAR T cells secreting an anti-CD33/anti-CD3 dual-targeting antibody overcome antigen heterogeneity in AML CAR T-cell therapy for paediatric solid tumours: clinical trial development and preclinical modelling Basic Cancer Immunology for Clinicians A Trispecific Antibody Induces Potent Tumor-Directed T-Cell Activation and Antitumor Activity by CD3/CD28 Co-Engagement On-demand GLUT3 expression augments CAR-T cell metabolic fitness and antitumor efficacy in glioblastoma models Affordable Immunotherapy – Opportunities and Challenges Affordable Immunotherapy: Opportunities and Challenges Cell Therapy for Solid Cancers – Promise or Overpromise? AP-SciBio 2027 x WIC APAC 2027 & Thai Immunology Annual Meeting TTCI to Participate in WIC-APAC 2026 Thailand Successfully Hosts Its First WIC APAC Webinar, Drawing Strong Regional Interest in Personalized Cancer Vaccines Cell Therapy for Solid Cancers: Promise or Overpromise? Antibody-Drug Conjugates (ADCs): Recent Advances in the Treatment of Solid Tumors TTCI Representative Highlights CAR-T Cell Therapy Roadmap at the 74th JSTMCT Annual Meeting in Yokohama TTCI Researchers Present and Collaborate at the 29th Annual Meeting of the Japanese Association of Cancer Immunology Antibody-Drug Conjugates (ADCs) – Recent Advances in the Treatment of Solid Tumors TTCI at a glance Chiang Mai University Team Government Agencies and Related Announcements IMMUNOLOGY SEMINAR: PEPTIDE CANCER VACCINE EXPERIENCE AT NCI White Paper Mahidol University Team On-demand GLUT3 expression augments CAR-T cell metabolic fitness and antitumor efficacy in glioblastoma models Pediatric Neuro-Oncology Consortium – Chulalongkorn University Research Forum NRCT Hosts Seminar on “Thai Cancer Immunotherapy: Collaboration, Regulation, and the Future of Treatment” at MHESI Fair 2025 Thai Immunology Annual Meeting 2026 IPOPI | SEAPID | Chulalongkorn | Erasmus MC Meeting 2026 TTCI Webinar “CAR T-cell Immunometabolism, Insights from Patients” Thammasat University Team Patient Care and Toxicities Management of CAR T-cell in Pediatrics International Collaborator Scientific Meeting: Medical Applications of Gene Editing and Synthetic Biology Technologies Chulalongkorn University Team Registration Open: 1st International Scientific Symposium in Hematologic Malignancy (CETH, Chulalongkorn University) Khonkaen University Team University of Wisconsin School of Medicine and Public Health Personalized Cancer Vaccines – A New Frontier in Thailand’s Fight Against Cancer